The transcription factor STAT2 enhances proteasomal degradation of RCAN1 through the ubiquitin E3 ligase FBW7

Biochemical and Biophysical Research Communications

Volumn 420, Issue 2, 2012, Pages 404-410

  Lee, Jee Won ^a   Kang, Hye Seon ^a   Lee, Jae Youn ^a   Lee, Eun Jung ^a   Rhim, Hyewhon ^b   Yoon, Joo Heon ^a   Seo, Su Ryeon ^c   Chung, Kwang Chul ^a  

^a Yonsei University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

DSCR1; FBW7; Inflammation; Interferon ; Proteasome; RCAN1; STAT2

Indexed keywords

ALPHA INTERFERON; CALCINEURIN; REGULATOR OF CALCINEURIN 1; STAT2 PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UBIQUITIN PROTEIN LIGASE E3 FBW7; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; UBIQUITINATION;

CELL CYCLE PROTEINS; CELL LINE, TUMOR; F-BOX PROTEINS; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-ALPHA; MUSCLE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; STAT2 TRANSCRIPTION FACTOR; UBIQUITIN-PROTEIN LIGASES;

MAMMALIA;

EID: 84862823681     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.007     Document Type: Article

References (23)

1. Fuentes J.J., Pritchard M.A., Estivill X. Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Genomics 1997, 44:358-361.
2. Harris C.D., Ermak G., Davies K.J. Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin1 (or RCAN1) in disease. Cell. Mol. Life Sci. 2005, 62:2477-2486.
3. Fuentes J.J., Genescà L., Kingsbury T.J., Cunningham K.W., Pérez-Riba M., Estivill X., de la Luna S. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum. Mol. Genet. 2000, 9:1681-1690.
4. Hilioti Z., Gallagher D.A., Low-Nam S.T., Ramaswamy P., Gajer P., Kingsbury T.J., Birchwood C.J., Levchenko A., Cunningham K.W. GSK-3 kinases enhance calcineurin signaling by phosphorylation of RCNs. Genes Dev. 2003, 18:35-47.
5. Rothermel B., Vega R.B., Yang J., Wu H., Bassel-Duby R., Williams R.S. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J. Biol. Chem. 2000, 275:8719-8725.
6. Genesca L., Aubareda A., Fuentes J.J., Estivill X., De La Luna S., Perez-Riba M. Phosphorylation of calcipressin 1 increases its ability to inhibit calcineurin and decreases calcipressin half-life. Biochem. J. 2003, 374:567-575.
7. Stark G.R., Kerr I.M., William B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 1998, 67:227-264.
8. Gutch M.J., Daly C., Reich N.C. Tyrosine phosphorylation is required for activation of an alpha interferon-stimulated transcription factor. Proc. Natl. Acad. Sci. USA 1992, 89:11411-11415.
9. Veals S.A., Schindler C., Leonard D., Fu X.Y., Aebersold R., Darnell J.E., Levy D.E. Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol. Cell. Biol. 1992, 12:3315-3324.
10. O'Shea J.J., Gadina M., Schreiber R.D. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 2002, 109:121-131.
11. Wang K., Wang C., Xiao F., Wang H., Wu Z. JAK2/STAT2/STAT3 are required for myogenic differentiation. J. Biol. Chem. 2008, 283:34029-34036.
12. Lee E.J., Seo S.R., Um J.W., Park J., Oh Y., Chung K.C. NF-kappaB-inducing kinase phosphorylates and blocks the degradation of Down syndrome candidate region 1. J. Biol. Chem. 2008, 283:3392-3400.
13. Lee J.Y., Lee H.J., Lee E.J., Jang S.H., Kim H., Yoon J.H., Chung K.C. Down syndrome candidate region-1 protein interacts with Tollip and positively modulates interleukin-1 receptor-mediated signaling. Biochim. Biophys. Acta 2009, 1790:1673-1680.
14. Leung S., Qureshi S.A., Kerr I.M., Darnell J.E., Stark G.R. Role of STAT2 in the alpha interferon signaling pathway. Mol. Cell. Biol. 1995, 15:1312-1317.
15. CDC4 ubiquitin ligase regulates calcineurin signaling through degradation of phosphorylated Rcn1, an inhibitor of calcineurin. Proc. Natl. Acad. Sci. USA 2007, 104:17418-17423.
16. Park J., Oh Y., Chung K.C. Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1. BMB Rep. 2009, 42:6-15.
17. Seo S.R., Chung K.C. CREB activates proteasomal degradation of DSCR1/RCAN1. FEBS Lett. 2008, 582:1889-1893.
18. Liu H., Wang P., Song W., Sun X. Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways. FASEB J. 2009, 23:3383-3392.
19. Asada S., Ikeda A., Nagao R., Hama H., Sudo T., Fukamizu A., Kasuya Y., Kishi T. Oxidative stress-induced ubiquitination of RCAN1 mediated by SCFbeta-TrCP ubiquitin ligase. Int. J. Mol. Med. 2008, 22:95-104.
20. Kim S.S., Seo S.R. Nedd4-2 ubiquitin ligase interacts with RCAN1 (DSCR1) for the proteasomal degradation. Genes Genom. 2010, 32:578-582.
21. Li X., Leung S., Qureshi S., Darnell J.E., Stark G.R. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-α. J. Biol. Chem. 1996, 271:5790-5794.
22. Bhattacharya S., Eckner R., Grossman S., Oldread E., Arany Z., D'Andrea A., Livingston D.M. Cooperation of Stat2 and p300/CBP in signaling induced by interferon- α. Nature 1996, 383:344-347.
23. Seo S.R., Lallemand F., Ferrand N., Pessah M., L'Hoste S., Camonis J., Atfi A. The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation. EMBO J. 2004, 23:3780-3792.